Home / Companies / News / Abbott India: More branded products, new launches, volumes to aid gains

Abbott India: More branded products, new launches, volumes to aid gains

The company outperformed most of its peers with a 6 per cent growth in revenues and a 450 basis points y-o-y expansion in operating profit margins

Premium

Growth going ahead is expected to be led by the branded business which accounts for 63 per cent of the company's revenues

Ram Prasad Sahu Mumbai

2 min read Last Updated : Aug 20 2020 | 12:32 AM IST

The Abbott India stock has gained over 13 per cent over the last couple of weeks on strong Q1 performance in a tough quarter. The company outperformed most of its peers with a 6 per cent growth in revenues and 450 basis points year-on-year (YoY) expansion in the operating profit margin.

According to analysts at ICICI Securities, growth was supported by the anti-diabetes portfolio of Novo Nordisk as the core portfolio of Abbott India is largely in acute therapy. The latter segment was primarily responsible for the weak performance of the pharma sector over the last couple of months.

The margin gains

Topics : Abbott India

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in